A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell Transplantation

The purpose of this study is to measure the effect of Hematopoietic Stem Cell Transplantation (HSCT) on symptoms of CSF1R-related Leukoencephalopathy.

Lead sponsor: Mayo Clinic•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

The Myelin Disorders Biorepository Project

NCT03047369 · Leukodystrophy, White Matter Disease, and more

RECRUITINGPhase 2

Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

NCT03428802 · BRCA1 Gene Mutation, BRCA2 Gene Mutation, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 8, 2026Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

Phase—

Enrollment20

Start dateJul 2020

Last updatedJan 8, 2026

Condition

Locations shown

Mayo Clinic in Florida

Jacksonville, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 8, 2026Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions